Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page
What's odd is that Pfizer keeps trying to sell products with no legs left. At least they put it in an existing sales force and not pay PDI to sell it. I like my prevnar rep and hope she can move some chantix
question is which bu is going away? Vaccines or Primary care.
PCBU keeps giving away volume (Pristiq to AZ, now Chantix/Premarin oral to share volume with Vac). Since PCBU and Vac areseperate profit centers, it's a loss of volume for PCBU increase for vaccines.
Vaccines. Prevnar has time to grow and now more products in the bag. PC has to find lower cost ways to sell old products. It's either Vaccines or P4, either way, we lose.